
Novartis Acquires Tourmaline Bio for $1.4 Billion
Novartis has announced its acquisition of Tourmaline Bio for $1.4 billion, a strategic move to enhance its biotechnology and cardiovascular portfolio. This acquisition signifies Novartis's commitment to expanding its capabilities in the biotech sector.

Novartis Acquires Tourmaline Bio for $1.4 Billion
Novartis has announced its acquisition of Tourmaline Bio for $1.4 billion, a strategic move to enhance its biotechnology and cardiovascular portfolio. This acquisition signifies Novartis's commitment to expanding its capabilities in the biotech sector.
Why World Pulse Now?
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Stories
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Multi-Language
Switch languages to read your way
Save for Later
Your stories, stored for later
Live Stats
Our system have analyzed 6,796 articles worldwide
That's roughly 283 articles per hour
531 trending stories shaping headlines worldwide
From breaking news to viral moments
AI-driven monitoring of 200 trusted sources, nonstop
From major news outlets to specialized publications
The latest update landed just an hour ago
We never sleep, so you're always informed
1-Minute Daily Briefing
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more
Why World Pulse Now?
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Stories
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Multi-Language
Switch languages to read your way
Save for Later
Your stories, stored for later
Live Stats
Our system have analyzed 6,796 articles worldwide
That's roughly 283 articles per hour
531 trending stories shaping headlines worldwide
From breaking news to viral moments
AI-driven monitoring of 200 trusted sources, nonstop
From major news outlets to specialized publications
The latest update landed just an hour ago
We never sleep, so you're always informed
1-Minute Daily Briefing
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more